COVID-19 (peds): Difference between revisions

No edit summary
 
(9 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{Peds top}} [[COVID-19]]. For transmission precautions see: [[Prevention of COVID-19 transmission in the healthcare setting]].
==Background==
==Background==
*No data currently exists to determine if children with underlying medical conditions (asthma, or special healthcare needs) at increased risk


==Clinical Features==
==Differential Diagnosis==
==Evaluation==
==Management==
==Disposition==
==See Also==
{{COVID see also}}
==External Links==
==References==
<references/>
==CHILDREN==
=== Epidemiology among Children ===
=== Epidemiology among Children ===
*2% of cases amongst < 2 years of age (NOTE: 13% in only one major city in China)
*2% of cases amongst < 2 years of age (NOTE: 13% in only one major city in China)
*Mostly because of household exposures (from adults)
*Mostly because of household exposures (from adults)
*Vast majority of cases in US are in adults
*Vast majority of cases in US are in adults
*Transmission in pediatrics
**Shedding for longer than adults (up to 22 days, some up to 30 days)
**Mostly goes from adults to children (not the other way around)


=== Symptoms in children ===
==Clinical Features==
===Acute Pediatric Presentation===
*Fever (50-80%), cough, congestion, rhinorrhea, sore throat  
*Fever (50-80%), cough, congestion, rhinorrhea, sore throat  
*GI in some cases (at least one case with GI sx first then respiratory symptoms after)
*GI in some cases (at least one case with GI sx first then respiratory symptoms after)
*50% of peds cases with fever, 30% with cough
*50% of peds cases with fever, 30% with cough


Disease Course
===Pediatric Disease Course===
*Mostly mild (for unclear reasons) except for only 2 cases:
*Mostly mild (for unclear reasons) except for only 2 cases:
**13 month developed ARDS and ICU care
**13 month developed ARDS and ICU care
**3 year old needed ICU
**3 year old needed ICU
*No deaths in children under 10 (from china so far)
*No deaths in children under 10 (from china so far)
*Radiographic: same as adults (bilateral, pulmonary lesions, GGO; some with unilateral).  
*Radiographic: same as adults (bilateral, pulmonary lesions, GGO; some with unilateral).
*Can rarely develop Multisystem inflammatory syndrome([[Multisystem inflammatory syndrome in children|MIS-C]])


=== Q&A ===
==Differential Diagnosis==
*Are children with underlying medical conditions (asthma, or special healthcare needs) at increased risk?
{{Pediatric fever DDX}}
** No data exists


=== Labs ===
==Evaluation==
===Workup===
 
===Diagnostic Findings===
*Mild CRP or AST elevations
*Mild CRP or AST elevations
*No consistency on WBC (mild leukocytosis, leukopenia)
*No consistency on WBC (mild leukocytosis, leukopenia)
*Few coinfections have been reported (with RSV, Influenza, mycoplasma).
*Few coinfections have been reported (with RSV, Influenza, mycoplasma).
**Coinfection unlikely (but possible) at this time
**Coinfection unlikely (but possible) at this time
Treatment
 
==Management==
''See [[prevention of COVID-19 transmission in the healthcare setting]] for PPE recommendations''
*Supportive care, isolation at home best unless needing hospitalisation
*Supportive care, isolation at home best unless needing hospitalisation
*Infection prevention and support!!! handwashing and PPE
*Infection prevention and support!!! handwashing and PPE
*No remdesavir trials in children
*No [[remdesavir]] trials in children


=== Transmission in Paediatrics ===
==Disposition==
*Shedding for longer than adults (up to 22 days, some up to 30 days)
*Mostly goes from adults to children (not the other way around)




=== HCW pediatric visits===
==See Also==
*CDC recommends decreased face-to-face triage
{{Special:Prefixindex/COVID-19 |hideredirects=1}}
*nurse -directed triage and telehealth visits
 
==External Links==
 
 
==References==
<references/>
 
[[Category:ID]]
[[Category:Pediatrics]]

Latest revision as of 18:31, 7 February 2024

This page is for pediatric patients. For adult patients, see: COVID-19. For transmission precautions see: Prevention of COVID-19 transmission in the healthcare setting.

Background

  • No data currently exists to determine if children with underlying medical conditions (asthma, or special healthcare needs) at increased risk

Epidemiology among Children

  • 2% of cases amongst < 2 years of age (NOTE: 13% in only one major city in China)
  • Mostly because of household exposures (from adults)
  • Vast majority of cases in US are in adults
  • Transmission in pediatrics
    • Shedding for longer than adults (up to 22 days, some up to 30 days)
    • Mostly goes from adults to children (not the other way around)

Clinical Features

Acute Pediatric Presentation

  • Fever (50-80%), cough, congestion, rhinorrhea, sore throat
  • GI in some cases (at least one case with GI sx first then respiratory symptoms after)
  • 50% of peds cases with fever, 30% with cough

Pediatric Disease Course

  • Mostly mild (for unclear reasons) except for only 2 cases:
    • 13 month developed ARDS and ICU care
    • 3 year old needed ICU
  • No deaths in children under 10 (from china so far)
  • Radiographic: same as adults (bilateral, pulmonary lesions, GGO; some with unilateral).
  • Can rarely develop Multisystem inflammatory syndrome(MIS-C)

Differential Diagnosis

Pediatric fever

Evaluation

Workup

Diagnostic Findings

  • Mild CRP or AST elevations
  • No consistency on WBC (mild leukocytosis, leukopenia)
  • Few coinfections have been reported (with RSV, Influenza, mycoplasma).
    • Coinfection unlikely (but possible) at this time

Management

See prevention of COVID-19 transmission in the healthcare setting for PPE recommendations

  • Supportive care, isolation at home best unless needing hospitalisation
  • Infection prevention and support!!! handwashing and PPE
  • No remdesavir trials in children

Disposition

See Also

External Links

References